Total Valuation
Neupath Health Inc. has a market cap or net worth of C$29.72M. The enterprise value is C$49.31.
Market CapC$29.72M
Enterprise ValueC$49.31
Share Statistics
Neupath Health Inc. has 55,030,310 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding55,030,310
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Neupath Health Inc.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count156
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Neupath Health Inc. is 25.1. Neupath Health Inc.’s PEG ratio is ―.
PE Ratio25.1
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Neupath Health Inc. had revenue of ― and earned -107.00K in profits. Earnings per share was ―.
Revenue―
Gross Profit12.30M
Operating Income216.00K
Pretax Income―
Net Income-107.00K
EBITDA3.59M
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Neupath Health Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.14
52-Week Price Change81.82%
50-Day Moving Average0.58
200-Day Moving Average0.55
Relative Strength Index (RSI)59.09
Average Volume (3m)63.04K
Important Dates
Neupath Health Inc. upcoming earnings date is Nov 12, 2026, Before Open (Confirmed).
Last Earnings DateAug 13, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
Neupath Health Inc. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Neupath Health Inc. has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Neupath Health Inc. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Neupath Health Inc. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Neupath Health Inc. is C$0.68, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$0.68
Price Target Upside23.64% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast12.05%
EPS Growth Forecast―